Comparing untreated L3 CFS with the TRY-treated one, the former was better in reducing IL-6 production in MRS without vitamin D (p < 0.0001), while the latter was more effective in the presence of vitamin D (p < 0.0001). This evidence concerns the gene IL6 and myalgic encephalomeyelitis/chronic fatigue syndrome.